Centene posts Q2 adjusted EPS of $2.51 as Medicaid rolls face 8%-9% 2026 decline
Question
Centene posts Q2 adjusted EPS of $2.51 as Medicaid rolls face 8%-9% 2026 decline
Direct answer
Centene Corporation posted Q2 2026 adjusted earnings per share of $2.51, reversing a year-ago quarterly loss. Improved medical cost ratios and tightened operational cost management drove the earnings recovery. The insurer guided for full-year 2026 Medicaid enrollment to drop 8% to 9%. Segment profit gains within ACA Marketplace coverage and Medicare Advantage plans are currently counterbalancing enrollment attrition.
- Original publisher
- Market Ontology
- Evidence through
- 2026-09-18
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-21
Cite as: Market Ontology, “Centene posts Q2 adjusted EPS of $2.51 as Medicaid rolls face 8%-9% 2026 decline”, revision 1, evidence through 2026-09-18. https://marketontology.com/market-events/2026-09-18/centene-posts-q2-adjusted-eps-of-2-51-as-medicaid-rolls-face-8-9-2026-decline-dc0331
How this development reaches the affected companies
| Asset | Exposure and channel | Direction | Evidence |
|---|---|---|---|
| CNC | underwriting margin recovery across ACA Marketplace and Medicare lines | Up1-4w | Centene reported Q2 2026 adjusted EPS of $2.51, recovering from a year-ago loss. |
| UNH | managed care medical cost ratio trajectory and Medicaid rate matching | Watch1-4w | UnitedHealth competes in government-sponsored and commercial health coverage. |
Does this development affect your holdings?
Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
What happened next
| Asset | Call | Base close | +1 day | +5 days | +20 days |
|---|---|---|---|---|---|
| CNC | Updisagreed | 65.11 2026-09-18 | -0.18% | -5.05% | Pending |
| UNH | Watch | 376.90 2026-09-18 | +0.18% | -0.08% | +6.51% |
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
No verifiable public source recorded for this card.
Related
- 2026-10-18UnitedHealth Reaffirms 13% to 16% Target as Q3 Prior Authorizations Fall 30%UNH XLV+1.36%
- 2026-10-18UnitedHealth reiterates 13-16% growth as AI cuts prior authorizations by 30%UNH XLV+1.36%
- 2026-10-18UnitedHealth Reaffirms 13% to 16% Target as Q3 Prior Authorizations Fall 30%UNH XLV+1.36%
- 2026-10-18UnitedHealth reiterates 13% to 16% growth target on 30% prior auth dropUNH XLV+1.36%
- 2026-10-18UnitedHealth reiterates 13% to 16% growth target on 30% prior auth dropUNH XLV+1.36%
- 2026-10-16BWXT, Johnson & Johnson, and UnitedHealth Raise FY26 OutlooksBWXT JNJ UNH+1.36%
- 2026-10-16UnitedHealth, J&J, and BWXT raise FY26 outlooks after solid quarterly earningsBWXT UNH+1.36%
- 2026-10-16UnitedHealth, J&J, and BWXT raise FY26 outlooks after solid quarterly earningsBWXT UNH+1.36%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.